|
End-of-day quote
Nasdaq
2026-10-20
|
5-day change | 1st Jan Change | ||
| 14.06 USD | +11.85% |
|
+19.66% | +7.90% |
| Oct. 20 | Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC | CI |
| Oct. 20 | Freenome Launches SimpleScreen Lung Cancer Test | MT |
| Market Cap | 1.37B 1.23B 1.13B 1.03B 1.92B 130B 1.95B 13.62B 5.39B 68.24B 5.15B 5.04B 215B | P/E 2026 * |
-6.48x | P/E 2027 * | -5.72x |
|---|---|---|---|---|---|
| Enterprise Value | 1.37B 1.23B 1.13B 1.03B 1.92B 130B 1.95B 13.62B 5.39B 68.24B 5.15B 5.04B 215B | EV / Sales 2026 * |
13.4x | EV / Sales 2027 * | 12.1x |
| Free-Float |
74.05% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FRNM | End-of-day quote | |
CBOE
| FRNM | Real-time |
| 1 day | +11.85% | ||
| 1 week | +19.66% | ||
| Current month | -10.73% | ||
| 1 month | -10.45% | ||
| 3 months | +15.25% | ||
| 6 months | +24.42% | ||
| Current year | +7.90% |
| 1 week | 11.79 |  | 14.42 |
| 1 month | 11.63 | | 17.3 |
| Current year | 9.95 | | 17.5 |
| 1 year | 9.95 | | 17.5 |
| 3 years | 9.95 | | 17.5 |
| 5 years | 9.95 | | 17.5 |
| 10 years | 9.95 | | 17.5 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Tax | Chief Executive Officer | -71,920 | 0.0669% | ||
| 7/20/26 | Other | Chief Executive Officer | 835,791 | 0.3889% | ||
| 7/20/26 | Conversion | -30,000 | 1.3913% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.85% | +19.66% | +31.65% | - | 1.37B | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +1.43% | +3.71% | +47.72% | +157.55% | 38.45B | |
| Weighted average by Cap. | +0.43% | +2.78% | +47.51% | +158.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 91.46M 84.49M 76.56M 143M 9.72B 146M 1.02B 403M 5.09B 384M 376M 16.06B | 114M 102M 93.91M 85.11M 159M 10.81B 162M 1.13B 447M 5.66B 427M 418M 17.85B |
| Net income | -175M -156M -144M -131M -245M -16.62B -249M -1.74B -688M -8.71B -657M -643M -27.46B | -246M -219M -203M -184M -344M -23.33B -349M -2.44B -966M -12.22B -922M -903M -38.53B |
| Net Debt | - | - |
Employees
378
Calendar
Nov. 10
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | $12.77 | -2.52% | 612,770 |
| 26-10-22 | $13.10 | -6.50% | 586,697 |
| 26-10-21 | $14.01 | -0.36% | 381,705 |
| 26-10-20 | $14.06 | +11.85% | 860,694 |
| 26-10-19 | $12.57 | +6.98% | 649,374 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
12.77USD
Average target price
18.00USD
Spread / Average Target
+40.96%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FRNM Stock
Select your edition
All financial news and data tailored to specific country editions
